Advagraf 5 mg (Tacrolimus CAPSULE (EXTENDED RELEASE)) 5 MG

ADVAGRAF 5 MG capsules are an extended-release formulation of tacrolimus, used to prevent organ rejection post-transplant. This immunosuppressant helps maintain organ function by reducing immune system activity.

Strength

5 MG

Pack Size

Manufacturer / TM Owner

ASTELLAS PHARMA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ADVAGRAF 5 MG is primarily used to prevent rejection of transplanted organs, such as kidneys, liver, or heart. It works by suppressing the immune system's response to the new organ. Tacrolimus is often prescribed to transplant patients to help their bodies accept the transplanted organ. What is ADVAGRAF used for? It is used for immunosuppression in transplant patients to prevent organ rejection.

Side Effects

Common effects of ADVAGRAF 5 MG may include tremors, headache, and increased blood pressure. Some users might experience insomnia, nausea, or diarrhea. These effects vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

ADVAGRAF 5 MG should be handled with care, as it is an immunosuppressant. It is important to follow the prescribed dosage and avoid activities that may increase the risk of infection. Regular monitoring of blood levels may be necessary to ensure safety and effectiveness.

Avoid Interactions

ADVAGRAF 5 MG may interact with certain medications, including CYP3A inhibitors and inducers. Alcohol and other immunosuppressants should be used with caution. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

ADVAGRAF is used to prevent organ rejection in transplant patients by suppressing the immune system.

ADVAGRAF 5 MG should be taken orally, typically once daily, as prescribed by a healthcare provider.

Common side effects may include tremors, headache, increased blood pressure, insomnia, nausea, or diarrhea.

ADVAGRAF may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

Long-term use of ADVAGRAF should be monitored by a healthcare provider to ensure safety and effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.